After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...

“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

Serena Williams stole the show at the premiere of Gucci's short film, The Tiger, in Milan on Tuesday. The tennis legend looked ethereal in a black gown with long sleeves and feathers trimming her ...

Sept 11 (Reuters) - LB Pharmaceuticals' shares rose 27% in their Nasdaq debut on Thursday, giving the biotech firm a valuation of $381.9 million and opening the door for companies looking to tap the ...

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial public offering of 19,000,000 shares of its common stock ...

LB Pharmaceuticals (LBRX), a drug developer focused on neuropsychiatric diseases has announced terms for its initial public offering on Nasdaq seeking a valuation of more than $300M according to a ...

Despite the stagnant biotech IPO market of the last six months, LB Pharmaceuticals has set out plans to reel in hundreds of millions of dollars through its upcoming public debut. The ...

LB Pharmaceuticals Inc (LBRX) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is a clinical-stage biopharma developing a drug ...